Analyze Diet
Frontiers in veterinary science2018; 5; 288; doi: 10.3389/fvets.2018.00288

Galectins-1 and-3 Increase in Equine Post-traumatic Osteoarthritis.

Abstract: Galectins are potent regulators of cell adhesion, growth and apoptosis in diverse cell types, including chondrocytes and synovial fibroblasts. Elevations in synovial fluid galectin-3 have been observed in rheumatoid arthritis, juvenile idiopathic arthritis and experimental inflammatory arthritis in animal models, whereas galectin-1 is thought to be protective. Less is known about galectins-1 and-3 in osteoarthritis (OA). Therefore, the purpose of this study was: (1) to determine whether galectin-1 and-3 synovial fluid concentrations and synovial membrane and cartilage histochemical staining were altered following osteochondral injury in an experimental equine osteoarthritis (OA) model and (2) to measure galectin-1 and-3 mRNA expression and synovial fluid concentrations in naturally occurring equine carpal OA. Synovial fluid galectin-1 and-3 concentrations were quantified using custom ELISAs in two research horse cohorts undergoing experimental OA induction ( = 5 and 4) and in a cohort of horses with naturally occurring carpal OA ( = 57). Galectin mRNA expression in synovial membrane and cartilage tissue obtained from carpal joints of horses with naturally occurring OA was measured using RT-qPCR, and galectin immunostaining was assessed in synovial membrane and osteochondral tissues in the experimental model ( = 5). Synovial fluid galectin-1 and-3 concentrations increased following experimental carpal osteochondral fragmentation. Cartilage galectin-1 mRNA expression increased with OA severity in naturally occurring disease. The superficial zone of healthy articular cartilage stained intensely for galectin-3 in sham-operated joints, whereas galectin-1 staining was nearly absent. Chondrocyte galectin-1 and-3 immunoreactivity increased following cartilage injury, particularly in galectin-1 positive chondrones. Galectins-1 and-3 are present in healthy equine synovial fluid and increase following post-traumatic OA. Healthy superficial zone chondrocytes express galectin-3, whereas galectin-1 chondrocyte staining is limited predominantly to chondrones and injured cartilage. Further work is needed to clarify the functions of galectins-1 and-3 in healthy and OA joints.
Publication Date: 2018-11-20 PubMed ID: 30525048PubMed Central: PMC6256174DOI: 10.3389/fvets.2018.00288Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper indicates that galectins-1 and-3, which help regulate cell behavior, increase after a traumatic joint injury, a development associated with the development of osteoarthritis (OA) in horses.

Research Approach

  • The purpose of the study was two-fold: firstly, to establish if galectin-1 and-3 concentrations, alongside their histochemical staining in the cartilage and synovial membrane, change post osteochondral injury using an equine osteoarthritis model; secondly, to measure galectin-1 and-3 mRNA expression and its concentration in synovial fluid from naturally occurring equine carpal OA.
  • The researchers conducted their study in two horse cohorts where experimental OA had been induced. They also had a cohort of horses with naturally occurring carpal OA.
  • The concentrations of galectin-1 and-3 in synovial fluid were quantified through custom enzyme-linked immunosorbent assays (ELISAs). Galectin mRNA expression in synovial membrane and cartilage tissue from horses with naturally occurring OA was measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR). Histochemical staining for galectin was assessed in synovial membrane and osteochondral tissues in the experimental model.

Key Findings

  • The researchers found that both galectin-1 and-3 concentrations increased post-traumatic osteochondral fragmentation. This suggests a role in injury response and potentially OA development.
  • The GALECTIN-1 mRNA in cartilage tissue showed elevated levels in direct relation to OA severity in naturally occurring disease. Thus, galectin-1 might be integral to the OA disease process.
  • Healthy articular cartilage showed intense galectin-3 presence, whereas galectin-1 was nearly absent. When cartilage was injured, both galectin-1 and-3 increased, suggesting their role in injury or repair processes at play in cartilage tissue.

Research Conclusions and Implications

  • Galectin-1 and-3, present in the synovial fluid of healthy horses, increased after traumatic joint injury, potentially implicating them in the ensuing OA development.
  • Further investigation is still required to establish the exact function of galectin-1 and-3 in normal and OA horse joints.
  • The results could potentially guide future therapeutic interventions targeting galectins-1 and-3 to halt or prevent osteoarthritis progression in horses, and potentially in humans, if found to be a shared physiological response.

Cite This Article

APA
Reesink HL, Nixon AJ, Su J, Liu S, Sutton RM, Mann S, Watts AE, Peterson RP. (2018). Galectins-1 and-3 Increase in Equine Post-traumatic Osteoarthritis. Front Vet Sci, 5, 288. https://doi.org/10.3389/fvets.2018.00288

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 5
Pages: 288
PII: 288

Researcher Affiliations

Reesink, Heidi L
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Nixon, Alan J
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Su, Jin
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Liu, Sherry
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Sutton, Ryan M
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Mann, Sabine
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Watts, Ashlee E
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Peterson, Ryan P
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.

References

This article includes 44 references
  1. Marsich E, Mozetic P, Ortolani F, Contin M, Marchini M, Vetere A, Pacor S, Semeraro S, Vittur F, Paoletti S. Galectin-1 in cartilage: expression, influence on chondrocyte growth and interaction with ECM components.. Matrix Biol 2008 Jul;27(6):513-25.
    doi: 10.1016/j.matbio.2008.04.003pubmed: 18558481google scholar: lookup
  2. Guévremont M, Martel-Pelletier J, Boileau C, Liu FT, Richard M, Fernandes JC, Pelletier JP, Reboul P. Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3.. Ann Rheum Dis 2004 Jun;63(6):636-43.
    doi: 10.1136/ard.2003.007229pmc: PMC1755017pubmed: 15140769google scholar: lookup
  3. Fowlis D, Colnot C, Ripoche MA, Poirier F. Galectin-3 is expressed in the notochord, developing bones, and skin of the postimplantation mouse embryo.. Dev Dyn 1995 Jun;203(2):241-51.
    doi: 10.1002/aja.1002030211pubmed: 7655085google scholar: lookup
  4. Reesink HL, Sutton RM, Shurer CR, Peterson RP, Tan JS, Su J, Paszek MJ, Nixon AJ. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.. Stem Cell Res Ther 2017 Nov 2;8(1):243.
    doi: 10.1186/s13287-017-0691-2pmc: PMC5667510pubmed: 29096716google scholar: lookup
  5. Colnot C, Sidhu SS, Balmain N, Poirier F. Uncoupling of chondrocyte death and vascular invasion in mouse galectin 3 null mutant bones.. Dev Biol 2001 Jan 1;229(1):203-14.
    doi: 10.1006/dbio.2000.9933pubmed: 11133164google scholar: lookup
  6. Boileau C, Poirier F, Pelletier JP, Guévremont M, Duval N, Martel-Pelletier J, Reboul P. Intracellular localisation of galectin-3 has a protective role in chondrocyte survival.. Ann Rheum Dis 2008 Feb;67(2):175-81.
    doi: 10.1136/ard.2006.066514pubmed: 17545192google scholar: lookup
  7. Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S, Neidhart M. Galectin 3 and its binding protein in rheumatoid arthritis.. Arthritis Rheum 2003 Oct;48(10):2788-95.
    doi: 10.1002/art.11287pubmed: 14558084google scholar: lookup
  8. Harjacek M, Diaz-Cano S, De Miguel M, Wolfe H, Maldonado CA, Rabinovich GA. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis.. J Rheumatol 2001 Aug;28(8):1914-22.
    pubmed: 11508600
  9. Ezzat MH, El-Gammasy TM, Shaheen KY, Osman AO. Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression.. Int J Rheum Dis 2011 Oct;14(4):345-52.
  10. Filer A, Bik M, Parsonage GN, Fitton J, Trebilcock E, Howlett K, Cook M, Raza K, Simmons DL, Thomas AM, Salmon M, Scheel-Toellner D, Lord JM, Rabinovich GA, Buckley CD. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways.. Arthritis Rheum 2009 Jun;60(6):1604-14.
    doi: 10.1002/art.24574pmc: PMC3116228pubmed: 19479862google scholar: lookup
  11. Li X, Zhao QY, Yuan FL. Galectin 3 as a novel therapeutic target in rheumatoid arthritis: comment on the article by Forsman et al.. Arthritis Rheum 2011 Oct;63(10):3179-80; author reply 3180.
    doi: 10.1002/art.30532pubmed: 21769835google scholar: lookup
  12. Xie Q, Ni M, Wang SC. Galectin-3, A Potential Therapeutic Target For Rheumatoid Arthritis?. Scand J Immunol 2018 Feb;87(2):108.
    doi: 10.1111/sji.12631pubmed: 29121412google scholar: lookup
  13. Xibillé-Friedmann D, Bustos Rivera-Bahena C, Rojas-Serrano J, Burgos-Vargas R, Montiel-Hernández JL. A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis.. Scand J Rheumatol 2013;42(2):102-7.
    doi: 10.3109/03009742.2012.725769pubmed: 23244209google scholar: lookup
  14. Iqbal AJ, Cooper D, Vugler A, Gittens BR, Moore A, Perretti M. Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.. J Immunol 2013 Jul 1;191(1):171-7.
    doi: 10.4049/jimmunol.1203291pmc: PMC3971374pubmed: 23720814google scholar: lookup
  15. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis.. J Exp Med 1999 Aug 2;190(3):385-98.
    pmc: PMC2195592pubmed: 10430627doi: 10.1084/jem.190.3.385google scholar: lookup
  16. Wang CR, Shiau AL, Chen SY, Cheng ZS, Li YT, Lee CH, Yo YT, Lo CW, Lin YS, Juan HY, Chen YL, Wu CL. Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis.. Gene Ther 2010 Oct;17(10):1225-33.
    doi: 10.1038/gt.2010.78pubmed: 20520649google scholar: lookup
  17. Huang YJ, Shiau AL, Chen SY, Chen YL, Wang CR, Tsai CY, Chang MY, Li YT, Leu CH, Wu CL. Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering.. Eur Cell Mater 2012 Mar 13;23:170-81; discussion 181.
    pubmed: 22415803doi: 10.22203/ecm.v023a13google scholar: lookup
  18. Forsman H, Islander U, Andréasson E, Andersson A, Onnheim K, Karlström A, Sävman K, Magnusson M, Brown KL, Karlsson A. Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis.. Arthritis Rheum 2011 Feb;63(2):445-54.
    doi: 10.1002/art.30118pubmed: 21280000google scholar: lookup
  19. Janelle-Montcalm A, Boileau C, Poirier F, Pelletier JP, Guévremont M, Duval N, Martel-Pelletier J, Reboul P. Extracellular localization of galectin-3 has a deleterious role in joint tissues.. Arthritis Res Ther 2007;9(1):R20.
    doi: 10.1186/ar2130pmc: PMC1860078pubmed: 17326835google scholar: lookup
  20. Alturfan AA, Eralp L, Emekli N. Investigation of inflammatory and hemostatic parameters in female patients undergoing total knee arthroplasty surgery.. Inflammation 2008 Dec;31(6):414-21.
    doi: 10.1007/s10753-008-9093-zpubmed: 19009338google scholar: lookup
  21. Toegel S, Weinmann D, André S, Walzer SM, Bilban M, Schmidt S, Chiari C, Windhager R, Krall C, Bennani-Baiti IM, Gabius HJ. Galectin-1 Couples Glycobiology to Inflammation in Osteoarthritis through the Activation of an NF-κB-Regulated Gene Network.. J Immunol 2016 Feb 15;196(4):1910-21.
    doi: 10.4049/jimmunol.1501165pubmed: 26792806google scholar: lookup
  22. Toegel S, Bieder D, André S, Altmann F, Walzer SM, Kaltner H, Hofstaetter JG, Windhager R, Gabius HJ. Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein.. Arthritis Res Ther 2013 Oct 4;15(5):R147.
    doi: 10.1186/ar4330pmc: PMC3978707pubmed: 24289744google scholar: lookup
  23. Toegel S, Bieder D, André S, Kayser K, Walzer SM, Hobusch G, Windhager R, Gabius HJ. Human osteoarthritic knee cartilage: fingerprinting of adhesion/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration.. Histochem Cell Biol 2014 Oct;142(4):373-88.
    doi: 10.1007/s00418-014-1234-xpubmed: 24981556google scholar: lookup
  24. Weinmann D, Schlangen K, André S, Schmidt S, Walzer SM, Kubista B, Windhager R, Toegel S, Gabius HJ. Galectin-3 Induces a Pro-degradative/inflammatory Gene Signature in Human Chondrocytes, Teaming Up with Galectin-1 in Osteoarthritis Pathogenesis.. Sci Rep 2016 Dec 16;6:39112.
    doi: 10.1038/srep39112pmc: PMC5159921pubmed: 27982117google scholar: lookup
  25. Iacobini C, Blasetti Fantauzzi C, Bedini R, Pecci R, Bartolazzi A, Amadio B, Pesce C, Pugliese G, Menini S. Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.. Metabolism 2018 Jun;83:149-158.
    doi: 10.1016/j.metabol.2018.02.001pubmed: 29432728google scholar: lookup
  26. McIlwraith C. Traumatic arthritis and posttraumatic osteoarthritis in the horse. In: McIlwraith C, Frisbie DD, Kawcak CE, van Weeren PR, editors. Joint Disease in the Horse. St. Louis: Elsevier; (2015). p. 33–55.
  27. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis.. Bone Joint Res 2012 Nov;1(11):297-309.
  28. Kuyinu EL, Narayanan G, Nair LS, Laurencin CT. Animal models of osteoarthritis: classification, update, and measurement of outcomes.. J Orthop Surg Res 2016 Feb 2;11:19.
    doi: 10.1186/s13018-016-0346-5pmc: PMC4738796pubmed: 26837951google scholar: lookup
  29. McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse.. Osteoarthritis Cartilage 2010 Oct;18 Suppl 3:S93-105.
    doi: 10.1016/j.joca.2010.05.031pubmed: 20864027google scholar: lookup
  30. Frisbie DD, Al-Sobayil F, Billinghurst RC, Kawcak CE, McIlwraith CW. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses.. Osteoarthritis Cartilage 2008 Oct;16(10):1196-204.
    doi: 10.1016/j.joca.2008.03.008pubmed: 18442931google scholar: lookup
  31. Frisbie DD, McIlwraith CW, Kawcak CE, Werpy NM. Evaluation of intra-articular hyaluronan, sodium chondroitin sulfate and N-acetyl-D-glucosamine combination versus saline (0.9% NaCl) for osteoarthritis using an equine model.. Vet J 2013 Sep;197(3):824-9.
    doi: 10.1016/j.tvjl.2013.05.033pubmed: 23838209google scholar: lookup
  32. Reesink HL, Watts AE, Mohammed HO, Jay GD, Nixon AJ. Lubricin/proteoglycan 4 increases in both experimental and naturally occurring equine osteoarthritis.. Osteoarthritis Cartilage 2017 Jan;25(1):128-137.
    doi: 10.1016/j.joca.2016.07.021pmc: PMC5489058pubmed: 27498214google scholar: lookup
  33. Kamm JL, Nixon AJ, Witte TH. Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi.. Equine Vet J 2010 Nov;42(8):693-9.
  34. Reesink HL, Bonnevie ED, Liu S, Shurer CR, Hollander MJ, Bonassar LJ, Nixon AJ. Galectin-3 Binds to Lubricin and Reinforces the Lubricating Boundary Layer of Articular Cartilage.. Sci Rep 2016 May 9;6:25463.
    doi: 10.1038/srep25463pmc: PMC4860590pubmed: 27157803google scholar: lookup
  35. Weinmann D, Kenn M, Schmidt S, Schmidt K, Walzer SM, Kubista B, Windhager R, Schreiner W, Toegel S, Gabius HJ. Galectin-8 induces functional disease markers in human osteoarthritis and cooperates with galectins-1 and -3.. Cell Mol Life Sci 2018 Nov;75(22):4187-4205.
    doi: 10.1007/s00018-018-2856-2pmc: PMC6182346pubmed: 29934665google scholar: lookup
  36. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.. Nat Rev Rheumatol 2010 Nov;6(11):625-35.
    doi: 10.1038/nrrheum.2010.159pubmed: 20924410google scholar: lookup
  37. Wang X, Hunter DJ, Jin X, Ding C. The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials.. Osteoarthritis Cartilage 2018 Feb;26(2):165-174.
    doi: 10.1016/j.joca.2017.11.015pubmed: 29224742google scholar: lookup
  38. Neidhart M, Rethage J, Kuchen S, Künzler P, Crowl RM, Billingham ME, Gay RE, Gay S. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression.. Arthritis Rheum 2000 Dec;43(12):2634-47.
  39. Issa SF, Christensen AF, Lindegaard HM, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K, Ejbjerg BJ, Lottenburger T, Ellingsen T, Pedersen JK, Junker K, Svendsen A, Tarp U, Østergaard M, Junker P. Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity.. Scand J Immunol 2017 Dec;86(6):471-478.
    doi: 10.1111/sji.12619pubmed: 28990250google scholar: lookup
  40. Chu CR, Szczodry M, Bruno S. Animal models for cartilage regeneration and repair.. Tissue Eng Part B Rev 2010 Feb;16(1):105-15.
    doi: 10.1089/ten.TEB.2009.0452pmc: PMC3121784pubmed: 19831641google scholar: lookup
  41. Li S, Yu Y, Koehn CD, Zhang Z, Su K. Galectins in the Pathogenesis of Rheumatoid Arthritis.. J Clin Cell Immunol 2013 Sep 30;4(5).
    doi: 10.4172/2155-9899.1000164pmc: PMC3886720pubmed: 24416634google scholar: lookup
  42. Smetana K Jr, André S, Kaltner H, Kopitz J, Gabius HJ. Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.. Expert Opin Ther Targets 2013 Apr;17(4):379-92.
    doi: 10.1517/14728222.2013.750651pubmed: 23289445google scholar: lookup
  43. Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential.. Expert Rev Mol Med 2008 Jun 13;10:e17.
    doi: 10.1017/S1462399408000719pubmed: 18549522google scholar: lookup
  44. Rabinovich GA. Galectin-1 as a potential cancer target.. Br J Cancer 2005 Apr 11;92(7):1188-92.
    doi: 10.1038/sj.bjc.6602493pmc: PMC2361964pubmed: 15785741google scholar: lookup

Citations

This article has been cited 8 times.
  1. Lönker NS, Fechner K, Wahed AAE. Horses as a Crucial Part of One Health. Vet Sci 2020 Feb 29;7(1).
    doi: 10.3390/vetsci7010028pubmed: 32121327google scholar: lookup
  2. Feeney E, Peal BT, Inglis JE, Su J, Nixon AJ, Bonassar LJ, Reesink HL. Temporal changes in synovial fluid composition and elastoviscous lubrication in the equine carpal fracture model. J Orthop Res 2019 May;37(5):1071-1079.
    doi: 10.1002/jor.24281pubmed: 30859611google scholar: lookup
  3. Lin C, Mi FL, Cha CY, Hsu FY, Ulfadillah SA, Tsai ML, Lu HT. Structurally reprogrammed modified citrus pectin (MCP) enables potentiated galectin-3 sequestration and injectable carboxymethyl chitosan/berberine hydrogel construction for osteoarthritis immunotherapy. Mater Today Bio 2025 Dec;35:102330.
    doi: 10.1016/j.mtbio.2025.102330pubmed: 41080725google scholar: lookup
  4. Ekinci G, Eren M, Yağlı K, Bendeş C, Ekebaş G, Tüfekçi E, Güzel S, Çakır Bayram L, Onmaz AC, Güneş V, Çitil M, Keleş İ. Evaluation of Cardiac Biomarkers in Lambs with White Muscle Disease. Vet Sci 2025 Aug 19;12(8).
    doi: 10.3390/vetsci12080774pubmed: 40872724google scholar: lookup
  5. Zhu C, Li Y, Wang H, Yang X, Wang Q. Serum levels of Galectin-1 and Galectin-3 for monitoring rheumatoid arthritis severity: a meta-analysis. Am J Transl Res 2025;17(5):3252-3260.
    doi: 10.62347/XGUP6698pubmed: 40535668google scholar: lookup
  6. Reihs E, Fischer A, Gerner I, Windhager R, Toegel S, Zaucke F, Rothbauer M, Jenner F. Beyond symptomatic alignment: evaluating the integration of causal mechanisms in matching animal models with human pathotypes in osteoarthritis research. Arthritis Res Ther 2025 May 17;27(1):109.
    doi: 10.1186/s13075-025-03561-4pubmed: 40382623google scholar: lookup
  7. Martinez-Saez L, Marín-García PJ, Llobat ML. Osteochondrosis in horses: An overview of genetic and other factors. Equine Vet J 2026 Jan;58(1):6-19.
    doi: 10.1111/evj.14518pubmed: 40302410google scholar: lookup
  8. Li J, Han N, Liu Z, Osman A, Xu L, Song J, Xiao Y, Hu W. Role of Galectin-3 in intervertebral disc degeneration: an experimental study. BMC Musculoskelet Disord 2024 Apr 1;25(1):249.
    doi: 10.1186/s12891-024-07382-5pubmed: 38561725google scholar: lookup